Clinical application of multidisclplinary team in the surgical treatment for non-small cell lung cancer_Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Authors：

CAO Xiong , LIN Ruijiang , LI Renpeng , ZHANG Yu ,  HAN Biao

Department of Thoracic Surgery, First Hospital of Lanzhou University, Lanzhou, 730000, P.R.China;

Corresponding?author：

HAN Biao, Email: hanbiao66@163.com

Keywords：

Multidisclplinary team; non-small cell lung cancer; surgical treatment

DOI：

10.7507/1007-4848.201811005

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To investigate the clinical value of multidisclplinary team (MDT) in the application of non-small cell lung cancer (NSCLC). Methods We retrospectively analyzed the postoperative clinical data of 80 patients with NSCLC in the First Hospital of Lanzhou University between January 2014 and May 2018. There were 56 males, 24 females at age of 59±10 years. Forty five patients were performed lobectomy with conventional model, 35 patients were also performed lobectomy after MDT discussion. The clinical effect of the two groups was compared. Results Compared to conventional model, MDT can shorten operation time, intraoperative blood loss, postoperative chest drainage, catheterization time, complications, length of stay and hospital costs. But there was no significant difference in intraoperative transthoracotomy proportion, delayed wound healing and postoperative pulmonary leakage between the two groups. Conclusion The efficacy of MDT in the surgical treatment of NSCLC is satisfactory. The MDT is valuable during operation, which reduces surgical trauma and accelerate patients’ recovery, and deserves the clinical promotion.

Citation： CAO Xiong, LIN Ruijiang, LI Renpeng, ZHANG Yu, HAN Biao. Clinical application of multidisclplinary team in the surgical treatment for non-small cell lung cancer. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2019, 26(8): 780-783. doi: 10.7507/1007-4848.201811005 Copy

1.	李曉雷, 徐俊, 胡欣, 等. 多中心多學科治療模式下對局部晚期非小細胞肺癌患者的新輔助化療療效及預后影響的臨床研究. 東南大學學報, 2018, 37(4): 667-672.
2.	聶俊, 何文杰, 江波. 肺癌多學科綜合診療模式的探討. 醫學與哲學, 2017, 2(38): 79-81.
3.	Behera M, Owonikoko TK, Chen Z, et al. Single-agent maintenance therapy for advanced stage non-small cell lung cancer: a meta-analysis. Lung Cancer, 2012, 77(2): 331-338.
4.	Andey T, Marepally S, Patel A, et al. Cationic lipid guided short-hairpin RNA interference of annexin A2 attenuates tumor growth and metastasis in a mouse lung cancer stem cell model. J Control Release, 2014, 184(7): 67-78.
5.	Siegel R, Naishadham D, Jemal A. Cancer statistics,2013. CA Cancer J Clin, 2013, 63(1): 11-30.
6.	Lamb BW, Green GS, Benn J, et al. Improving decision making in multidisiciplinary tumor boards: prospective longitudinal evaluation of a multicomponent intervention for 1421 patients. J Am Coll Surg, 2013, 217(3): 412-420.
7.	Prades J, Borras JM. Shifting sands: adapting the multidisciplinary team model to technological and organizational innovations in cancer care. Future Oncol, 2014, 10(13): 1995-1998.
8.	Denton E, Conron M. Improving outcomes in lung cancer:the value of the multidisciplinary healthcare team. J Multidiscip Healthc, 2016, 30(9): 137-144.
9.	呂文平, 張文智, 蔡守旺, 等. 多學科協作診療模式應用初探. 中華醫學科研管理雜志, 2012, 25(1): 48.
10.	趙玉沛. 重視胰腺癌的多學科診療. 中華外科雜志, 2016, (11): 801-803.
11.	Gaga M, Powell CA, Schraufnagel DE, et al. An official American Thoracic Society/European Respiratory Society Statement: The Role of the Pulmonologist in the Diagnosis and Management of Lung Cancer. Am J Respir Crit Care Med, 2013, 188(4): 503-507.
12.	劉成武, 劉倫旭. 肺癌微創外科治療進展. 中華胸部外科電子雜志, 2016, 3(2): 65-69.
13.	吳一旻, 柴瑩. 單孔胸腔鏡在肺癌外科中的應用進展. 國際外科學雜志, 2016, 43(5): 357-360.
14.	劉成武, 劉倫旭. 單孔胸腔鏡: 微創肺癌切除的再次升華. 中國肺癌雜志, 2014, 17(7): 527-530.
15.	Liu CY, Lin CS, Shih CH, et al. Single-port video-assisted thoracoscopic surgery for lung cancer. J Thorac Dis, 2014, 6(1): 1421.
16.	McKenna RJ Jr, Houck W, Fuller CB. Video-assisted thoracic surgery lobectomy: experience with 1, 100 cases. Ann Thorac Surg, 2006, 81(2): 421-425.
17.	Samson P, Guitron J, Reed MF, et al. Predictors of conversion to thoracotomy for video-assisted thoracoscopic lobectomy: a retrospective analysis and the influence of computed tomographybased calcification assessment. J Thorac Cardiovasc Surg, 2013, 145(6): 1512-1518.
18.	Byun CS, Lee S, Kim DJ, et al. Analysis of unexpected conversion to thoracotomy during thoracoscopic lobectomy in lung cancer. Ann Thorac Surg, 2015, 100(3): 968-973.
19.	Augustin F, Maier HT, Weissenbacher A, et al. Causes, predictors and consequences of conversion from VATS to open lung lobectomy. Surg Endosc, 2016, 30(6): 2415-2421.
20.	方丹青, 葛林虎, 彭品賢, 等. 胸腔鏡手術危險因素分析及并發癥防治. 中國內鏡雜志, 2006, 12(3): 278-281.

1. 李曉雷, 徐俊, 胡欣, 等. 多中心多學科治療模式下對局部晚期非小細胞肺癌患者的新輔助化療療效及預后影響的臨床研究. 東南大學學報, 2018, 37(4): 667-672.
2. 聶俊, 何文杰, 江波. 肺癌多學科綜合診療模式的探討. 醫學與哲學, 2017, 2(38): 79-81.
3. Behera M, Owonikoko TK, Chen Z, et al. Single-agent maintenance therapy for advanced stage non-small cell lung cancer: a meta-analysis. Lung Cancer, 2012, 77(2): 331-338.
4. Andey T, Marepally S, Patel A, et al. Cationic lipid guided short-hairpin RNA interference of annexin A2 attenuates tumor growth and metastasis in a mouse lung cancer stem cell model. J Control Release, 2014, 184(7): 67-78.
5. Siegel R, Naishadham D, Jemal A. Cancer statistics,2013. CA Cancer J Clin, 2013, 63(1): 11-30.
6. Lamb BW, Green GS, Benn J, et al. Improving decision making in multidisiciplinary tumor boards: prospective longitudinal evaluation of a multicomponent intervention for 1421 patients. J Am Coll Surg, 2013, 217(3): 412-420.
7. Prades J, Borras JM. Shifting sands: adapting the multidisciplinary team model to technological and organizational innovations in cancer care. Future Oncol, 2014, 10(13): 1995-1998.
8. Denton E, Conron M. Improving outcomes in lung cancer:the value of the multidisciplinary healthcare team. J Multidiscip Healthc, 2016, 30(9): 137-144.
9. 呂文平, 張文智, 蔡守旺, 等. 多學科協作診療模式應用初探. 中華醫學科研管理雜志, 2012, 25(1): 48.
10. 趙玉沛. 重視胰腺癌的多學科診療. 中華外科雜志, 2016, (11): 801-803.
11. Gaga M, Powell CA, Schraufnagel DE, et al. An official American Thoracic Society/European Respiratory Society Statement: The Role of the Pulmonologist in the Diagnosis and Management of Lung Cancer. Am J Respir Crit Care Med, 2013, 188(4): 503-507.
12. 劉成武, 劉倫旭. 肺癌微創外科治療進展. 中華胸部外科電子雜志, 2016, 3(2): 65-69.
13. 吳一旻, 柴瑩. 單孔胸腔鏡在肺癌外科中的應用進展. 國際外科學雜志, 2016, 43(5): 357-360.
14. 劉成武, 劉倫旭. 單孔胸腔鏡: 微創肺癌切除的再次升華. 中國肺癌雜志, 2014, 17(7): 527-530.
15. Liu CY, Lin CS, Shih CH, et al. Single-port video-assisted thoracoscopic surgery for lung cancer. J Thorac Dis, 2014, 6(1): 1421.
16. McKenna RJ Jr, Houck W, Fuller CB. Video-assisted thoracic surgery lobectomy: experience with 1, 100 cases. Ann Thorac Surg, 2006, 81(2): 421-425.
17. Samson P, Guitron J, Reed MF, et al. Predictors of conversion to thoracotomy for video-assisted thoracoscopic lobectomy: a retrospective analysis and the influence of computed tomographybased calcification assessment. J Thorac Cardiovasc Surg, 2013, 145(6): 1512-1518.
18. Byun CS, Lee S, Kim DJ, et al. Analysis of unexpected conversion to thoracotomy during thoracoscopic lobectomy in lung cancer. Ann Thorac Surg, 2015, 100(3): 968-973.
19. Augustin F, Maier HT, Weissenbacher A, et al. Causes, predictors and consequences of conversion from VATS to open lung lobectomy. Surg Endosc, 2016, 30(6): 2415-2421.
20. 方丹青, 葛林虎, 彭品賢, 等. 胸腔鏡手術危險因素分析及并發癥防治. 中國內鏡雜志, 2006, 12(3): 278-281.

Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Clinical application of multidisclplinary team in the surgical treatment for non-small cell lung cancer

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content